Notable Analyst Rating Changes 5/14: PFG, JCI, ANF, CME Upgraded; LPX, AZN, STV Downgraded
More News related to ANF
- Aeropostale (ARO) Delivers In 3Q, But Important 4Q Guidance Not Rosy Enough
- FBR Research Upgrades Abercrombie & Fitch (ANF) to Outperform; Strong Channel Checks
- Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
- Caris & Co Upgrades Abercrombie & Fitch (ANF) to Average
- Highlights From ANF's Q3 Conference Call: Net Sales Declined 15%, Comp Store Sales Fell 22%
More News related to AZN
- Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
- AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
- AstraZeneca (AZN) Submits NDA to U.S. FDA for Ticagrelor
- AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
More News related to CME
- CME Group's Duffy to Testify before Senate Committee on Agriculture
- CME Group Volume Averaged 10.8 Million Contracts per Day in November 2009, Up 5 Percent from November 2008
- CME Group, KRX Announce After-hours Access to KOSPI 200 Futures on CME Globex
- CME Group Announces the Launch of Dow Jones-UBS Commodity Index Swap Futures
- CME Group (CME) Declares $1.15 Quarterly Dividend; 1.5% Yield
More News related to Special Reports
- After-Hours Movers 12/02: KTCC, PSS, SEAC, BAC Higher; SIGM, SNPS, ARO, JAS, VRTX Lower
- Trading Radar for 12/3: Marvell (MRVL), Toll Bros. (TOL), Del Monte (DLM), Smith & Wesson (SWHC) Report
- Unusual 11 Mid-Day Movers 12/02: ABCW, BIOF, GRH, STEM Higher; HEB, HDY, BGP, CBAK Lower
- Notable ETF Movers 12/2: GDX, TUR Up; UNG, USO, THD Down
- Notable Analyst Rating Changes 12/2: AMR/UAUA, RFMD, STI, SAY, KBH, BBT Upgraded; STZ, MTL, BWP, POM Downgraded
UPGRADES:
Goldman Sachs upgrades Principal Financial Group Inc. (NYSE: PFG) from Sell to Neutral and raises its price target from $18 to $20.
Wachovia Securities upgrades Johnson Controls (NYSE: JCI) to Outperform. Valuation range raised to $29-31. Click here for full color on the upgrade.
Susquehanna upgrades Abercrombie & Fitch (NYSE: ANF) from Neutral to Positive with a $33 price target, saying cost cuts and international provide upside. Click here for the full report.
JP Morgan upgrades CME Group (NYSE: CME) from Underweight to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Credit Suisse downgrades Louisiana-Pacific (NYSE: LPX) from Neutral to Underperform.
Jefferies & Co downgrades AstraZeneca (NYSE: AZN) from Hold to Underperform.
Credit Suisse downgrades China Digital (NYSE: STV) from Outperform to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Joseph Starts L-3 Communications Holdings (NYSE: LLL) at Hold. Click here for full color on the coverage.
Soleil Securities initiates coverage on Valeant Pharmaceuticals Int (NYSE: VRX) with a Sell rating and $14 price target, saying declining base and pipeline concerns leave VRX overvalued. Here is the full report.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.16
+0.19Related Entities
- Credit Suisse
- JPMorgan
- Goldman Sachs
- Jefferies & Co
- Wachovia
- Soleil Securities
- Morgan Joseph
- Susquehanna International Group of Companies
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
